Jason B. Dinoso, Ph.D.
Affiliations: | 2010 | Johns Hopkins University, Baltimore, MD |
Area:
Microbiology Biology, Immunology, Virology BiologyGoogle:
"Jason Dinoso"Parents
Sign in to add mentorRobert F. Siliciano | grad student | 2010 | Johns Hopkins | |
(Understanding the nature Human Immunodeficiency Virus type 1 (HIV-1) persistence in individuals on suppressive highly active antiretroviral therapy.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Queen SE, Mears BM, Kelly KM, et al. (2011) Replication-competent simian immunodeficiency virus (SIV) Gag escape mutations archived in latent reservoirs during antiretroviral treatment of SIV-infected macaques. Journal of Virology. 85: 9167-75 |
Gaillard S, Dinoso JB, Marsh JA, et al. (2011) Sustained elite suppression of replication competent HIV-1 in a patient treated with rituximab based chemotherapy. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 51: 195-8 |
O'Connell KA, Pelz RK, Dinoso JB, et al. (2010) Prolonged control of an HIV type 1 escape variant following treatment interruption in an HLA-B*27-positive patient. Aids Research and Human Retroviruses. 26: 1307-11 |
Margolick JB, Imteyaz H, Gallant JE, et al. (2010) Prolonged viral suppression without therapy in an HIV-1 seroconverter following early antiretroviral therapy and daily interleukin-2. Aids (London, England). 24: 932-5 |
Sedaghat AR, Rastegar DA, O'Connell KA, et al. (2010) Reply to torre Clinical Infectious Diseases. 50: 1425-1426 |
Sedaghat AR, Rastegar DA, O'Connell KA, et al. (2009) T cell dynamics and the response to HAART in a cohort of HIV-1-infected elite suppressors. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 49: 1763-6 |
Yang HC, Xing S, Shan L, et al. (2009) Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation. The Journal of Clinical Investigation. 119: 3473-86 |
Dinoso JB, Rabi SA, Blankson JN, et al. (2009) A simian immunodeficiency virus-infected macaque model to study viral reservoirs that persist during highly active antiretroviral therapy. Journal of Virology. 83: 9247-57 |
Dinoso JB, Kim SY, Wiegand AM, et al. (2009) Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy. Proceedings of the National Academy of Sciences of the United States of America. 106: 9403-8 |
Dinoso JB, Kim SY, Siliciano RF, et al. (2008) A comparison of viral loads between HIV-1-infected elite suppressors and individuals who receive suppressive highly active antiretroviral therapy. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 47: 102-4 |